MetaboHealth, Metabolic Vulnerability Index, genetic susceptibility and the risk of psoriatic disease
British Journal of Dermatology · 2026-10-01
DOI: 10.1093/bjd/ljag433 ↗Abstract
Previous studies of metabolic dysregulation in psoriatic disease (PsD) have largely focused on single metabolic factors. Comprehensive scores, such as MetaboHealth and the Metabolic Vulnerability Index (MVX), have not been systematically explored in PsD. In this prospective cohort study using UK Biobank data, we showed that MetaboHealth and MVX were associated with PsD risk independent of confounders, particularly in individuals with a high genetic predisposition.
EUVIMED